Evolent Health (EVH) Depreciation & Amortization (CF) (2015 - 2026)

Evolent Health has reported Depreciation & Amortization (CF) for 12 years, with the latest figure at $21.6 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 6.81% year-over-year to $21.6 million in Q2 2026; TTM through Jun 2026 was $111.8 million, a 5.25% increase from a year earlier, with the FY2025 full-year figure at $115.9 million, down 2.13% from the prior year.
• Depreciation & Amortization (CF) was $21.6 million for Q2 2026 at Evolent Health, roughly flat from $21.6 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $45.0 million in Q4 2025, with the low at $15.1 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $26.0 million, with a median of $26.7 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) jumped 112.64% in 2023, then slipped 22.53% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $19.8 million in 2022, then jumped by 49.65% to $29.6 million in 2023, then declined by 1.03% to $29.3 million in 2024, then soared by 53.73% to $45.0 million in 2025, then tumbled by 52.11% to $21.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $21.6 million (Q2 2026), $21.6 million (Q1 2026), and $45.0 million (Q4 2025), per Business Quant data.